abstract |
The present invention provides pharmaceutical formulations for oral administration of antisense oligonucleotides such as antisense oligonucleotides against SMAD7. The pharmaceutical formulations may be used for the treatment of Crohn's disease, ulcerative colitis, and chronic inflammatory bowel disease. |